ZNF667 and central nervous system cancer: To determine the possible functions of ZNF667-AS1 in glioma, we enrolled 155 glioma patients and performed RT-PCR to examine the expression of ZNF667-AS1 in a total of 155 paired glioma tissues and corresponding nontumor tissues.